FDA Approved: COPIKTRA — Supplemental Application (Secura Bio, Inc)

View source ↗

Summary

The FDA has approved a supplemental application for COPIKTRA (duvelisib) by Secura Bio, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• COPIKTRA (duvelisib)

Snippet

SUPPL AP for COPIKTRA (DUVELISIB)